https://www.selleckchem.com/pr....oducts/Gefitinib.htm
Gliomas are the malignance of a poor prognosis. The current WHO classification remains unable to predict survival outcomes accurately. Novel surrogates are highly required for improved stratification of patients and hence, allowing to delivery of the most appropriate treatment. Transcriptional profiles of 301 glioma cases on the platform of Chinese Glioma Genome Atlas (CGGA) were retrospectively studied. Extracellular matrix (ECM) scores were established by integrating a panel of most featured gene-signatures, correlating well with pa
Beğen
Yorum Yap
Paylaş
